NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus NALIRIFOX as Conversion Therapy of Locally Advanced Pancreatic Cancer
Clinical trial NCT06669078 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06669078
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-30
- Primary completion
- 2027-10-15
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.